EXHIBIT 99.1 Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market Share Gains ; Third Quarter 2024 Infant formula Net Sales Growth of +3% Compared to the Prior Year Quarter, +58% Sequentially 1 Reaffirms Fiscal 2024 Adjusted EPS Outloo ...